Literature DB >> 26941390

The heads and the tails of malaria and VWF.

Robert R Montgomery1.   

Abstract

In this issue of Blood, O'Regan et al have extended our understanding of von Willebrand factor (VWF) in the pathogenesis of malaria. According to the World Health Organization (http://www.who.int/gho/malaria/en/), malaria affects 3.2 billion people in 97 countries with 198 million cases having occurred in 2013, and of those, 584 000 died. Ninety percent of those deaths in 2013 were children under the age of 5. The most devastating form of the disease is cerebral malaria, which occurs most frequently in young children. Although blood coagulation changes such as disseminated intravascular coagulation have been recognized since the 1970s, recent studies have focused on markers of these hemostatic changes as being most prevalent in cerebral malaria caused by Plasmodium falciparum. Cerebral malaria is more lethal in children than adults. Exchange transfusion has been used as an aggressive adjunct therapy for this condition.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26941390     DOI: 10.1182/blood-2015-11-679878

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  2 in total

1.  Functional changes in hemostasis during asexual and sexual parasitemia in a controlled human malaria infection.

Authors:  Shengshi Huang; Wouter van der Heijden; Isaie J Reuling; Jun Wan; Qiuting Yan; Romy M W de Laat-Kremers; Andre J Van der Ven; Philip G de Groot; Matthew McCall; Robert W Sauerwein; Teun Bousema; Mark Roest; Marisa Ninivaggi; Quirijn de Mast; Bas de Laat
Journal:  PLoS One       Date:  2022-07-15       Impact factor: 3.752

2.  Multiplexed quantitative proteomics provides mechanistic cues for malaria severity and complexity.

Authors:  Vipin Kumar; Sandipan Ray; Shalini Aggarwal; Deeptarup Biswas; Manali Jadhav; Radha Yadav; Sanjeev V Sabnis; Soumaditya Banerjee; Arunansu Talukdar; Sanjay K Kochar; Suvin Shetty; Kunal Sehgal; Swati Patankar; Sanjeeva Srivastava
Journal:  Commun Biol       Date:  2020-11-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.